Georganne Vogt, NP
Payments from drug & device makers
Across 129 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$488
- AbbVie$353
- Amgen$222
- Lilly USA, LLC$222
- Boehringer Ingelheim$168
- Pfizer$152
- plus $698 from 17 others
What the payments were for
- Food & beverage$2,301100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $488 |
| AbbVie | 20 | $353 |
| Amgen | 13 | $222 |
| Lilly USA, LLC | 17 | $222 |
| Boehringer Ingelheim | 10 | $168 |
| Pfizer | 7 | $152 |
| Novo Nordisk | 6 | $111 |
| Corium, LLC | 3 | $84 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $80 |
| GSK | 4 | $79 |
| Novartis | 4 | $76 |
| Dexcom, Inc. | 3 | $49 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Idorsia Pharmaceuticals US Inc | 2 | $31 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Bausch Health US, LLC | 1 | $17 |
| Merck | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Genentech USA, Inc. | 1 | $5 |
How this compares
$2,301 in reported general payments places this provider in the 80th percentile of 6,258 family providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 37 | $616 |
| Olmesartan Medoxomil | 21 | $490 |
| Rosuvastatin Calcium | 25 | $326 |
| Pantoprazole Sodium | 23 | $325 |
| Ezetimibe | 13 | $319 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $264 |
| Atorvastatin Calcium | 31 | $225 |
| Omeprazole | 37 | $217 |
| Gabapentin | 29 | $214 |
| Amlodipine Besylate | 24 | $193 |
| Lisinopril | 29 | $177 |
| Bupropion XlBupropion Hcl | 12 | $158 |
| Azithromycin | 42 | $153 |
| Hydrochlorothiazide | 17 | $119 |
| Buspirone Hcl | 15 | $116 |
Paid to pharmacies, not to this prescriber.
Other family in Macon
- Villanueva SpiveyMacon$18K
- Allie McAllisterMarietta$299K
- Tonita WashingtonLawrenceville$153K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.